GXE:ETR
Lakefront Biotherapeutics NV
€26.10
arrow_downward
-0.68%(-0.18) 1D
Oct 14, 4:50:20 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GXE...
Open
€25.98
High
€26.10
Low
€25.74
Mkt. cap
1.72B
Avg. vol.
572.00
Volume
574.00
P/E ratio
2.88
52-wk high
€30.02
52-wk low
€22.84
EPS
€9.05
No. of employees
196
Open
€25.98
High
€26.10
Low
€25.74
Mkt. cap
1.72B
Avg. vol.
572.00
Volume
574.00
P/E ratio
2.88
52-wk high
€30.02
52-wk low
€22.84
EPS
€9.05
No. of employees
196
News stories
From web sources and news partners
ChartMill
·
40 minutes ago
These S&P500 stocks are gapping in today's session
TradingView
·
1 hour ago
The Dow Jones Index Opens 0.26% Higher
Seeking Alpha
·
27 minutes ago
Ratio of small caps vs. large caps falls to lowest level since 2025 (SP500:)
Yahoo Finance
·
1 hour ago
This ETF Has Crushed the S&P 500 in 2026. Here's Why I Think It Still Has Room to Grow.
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Websitelakefrontbio.com